|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.5 TWD | -0.51% |
|
+7.14% | -6.25% |
Genomics BioSci & Tech. Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 205.22 million compared to TWD 192.86 million a year ago.
Net income was TWD 67.91 million compared to TWD 41.3 million a year ago. Basic earnings per share from continuing operations was TWD 1.0861 compared to TWD 0.6824 a year ago. Diluted earnings per share from continuing operations was TWD 1.0861 compared to TWD 0.6824 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.25% | 43.32M | |
| +0.17% | 42.19B | |
| +10.92% | 42.24B | |
| +44.30% | 40.15B | |
| -6.20% | 28.31B | |
| +5.23% | 24.63B | |
| -24.79% | 18.2B | |
| +26.69% | 12.01B | |
| -3.13% | 11.76B | |
| +6.57% | 10.4B |
GENOMICS BIOSCI & TECH. CO.,LTD. 
